Literature DB >> 1690428

Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells.

D K Trask1, V Band, D A Zajchowski, P Yaswen, T Suh, R Sager.   

Abstract

Keratin 5 (K5) mRNA and protein are shown to be expressed in normal mammary epithelial cells in culture and are absent from tumor-derived cell lines. To extend these findings, the full complements of keratins in normal, immortalized, and tumor cells were compared. It is shown here that normal cells produce keratins K5, K6, K7, K14, and K17, whereas tumor cells produce mainly keratins K8, K18, and K19. In immortalized cells, which are preneoplastic or partially transformed, the levels of K5 mRNA and protein are lower than in normal cells, whereas the amount of K18 is increased. Thus, K5 is an important marker in the tumorigenic process, distinguishing normal from tumor cells, and decreased K5 expression correlates with tumorigenic progression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690428      PMCID: PMC53678          DOI: 10.1073/pnas.87.6.2319

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations.

Authors:  D Cooper; A Schermer; T T Sun
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

2.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.

Authors:  R B Nagle; W Böcker; J R Davis; H W Heid; M Kaufmann; D O Lucas; E D Jarasch
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

3.  Isolation, sequence, and expression of a human keratin K5 gene: transcriptional regulation of keratins and insights into pairwise control.

Authors:  R Lersch; V Stellmach; C Stocks; G Giudice; E Fuchs
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium.

Authors:  K Lindberg; J G Rheinwald
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Sequence and expression of a type II keratin, K5, in human epidermal cells.

Authors:  R Lersch; E Fuchs
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Keratin immunoreactivity in the benign and neoplastic human prostate.

Authors:  M K Brawer; D M Peehl; T A Stamey; D G Bostwick
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

8.  Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.

Authors:  S H Dairkee; L Puett; A J Hackett
Journal:  J Natl Cancer Inst       Date:  1988-07-06       Impact factor: 13.506

9.  A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes.

Authors:  V Band; D Zajchowski; G Stenman; C C Morton; V Kulesa; J Connolly; R Sager
Journal:  Genes Chromosomes Cancer       Date:  1989-09       Impact factor: 5.006

10.  Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium.

Authors:  J Taylor-Papadimitriou; M Stampfer; J Bartek; A Lewis; M Boshell; E B Lane; I M Leigh
Journal:  J Cell Sci       Date:  1989-11       Impact factor: 5.285

View more
  49 in total

Review 1.  Stem cells in the human breast.

Authors:  Ole William Petersen; Kornelia Polyak
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

Review 2.  The application of 2D gel-based proteomics methods to the study of breast cancer.

Authors:  Robert C Stein; Marketa J Zvelebil
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

3.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

Authors:  O W Petersen; L Rønnov-Jessen; A R Howlett; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells.

Authors:  P Yaswen; A Smoll; D M Peehl; D K Trask; R Sager; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.

Authors:  P Meleady; M Clynes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

6.  Micro-proteome analysis using micro-chromatofocusing in intact protein separations.

Authors:  Hyeyeung Kim; David M Lubman
Journal:  J Chromatogr A       Date:  2008-03-27       Impact factor: 4.759

Review 7.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

8.  Expression of complete keratin filaments in mouse L cells augments cell migration and invasion.

Authors:  Y W Chu; R B Runyan; R G Oshima; M J Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins.

Authors:  Kristi A Egland; James J Vincent; Robert Strausberg; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.